Product Information

LAMOTRIGINE ER 200 MG TABLET is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.6180 per EA under NDC 68382098206. Its NADAC has been published 305 times since Oct 21, 2020.

FDA first approved this application on Apr 1, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

LAMOTRIGINE ER 200 MG TABLET

Lamotrigine
$0.6180per EA

Strength

200 mg/1

NDC

68382098206

Classification

Generic

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

LAMOTRIGINE

Approval Type

Generic (ANDA)

FDA Application

ANDA207763

FDA Approved

4/1/2020

TE Code

AB

On Market Since

5/14/2020

Pharmacological Classes

Anti-epileptic Agent
Decreased Central Nervous System Disorganized Electrical Activity
Dihydrofolate Reductase Inhibitors
Mood Stabilizer
Organic Cation Transporter 2 Inhibitors

Price Statistics

The NADAC for LAMOTRIGINE ER 200 MG TABLET has been published 305 times since Oct 21, 2020, and over the history we have for it it has declined 69.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.6180 per EA
All-time high$2.3296 (Oct 13, 2021)
All-time low$0.4877 (Nov 20, 2024)
52-week high$0.8449
52-week low$0.6180
Median price$0.9191
Average price$1.1567
Largest weekly change-39.7% (Nov 20, 2024)
Weeks tracked305
Tracking sinceOct 21, 2020

Price History

1W

-11.1%

1M

-11.1%

3M

-20.2%

6M

-17.7%

1Y

-26.9%

3Y

-31.6%

5Y

-72.2%

All

-69.8%

Generic Alternatives

The matcher finds 16 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 86% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of LAMOTRIGINE ER 200 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for LAMOTRIGINE ER 200 MG TABLET, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.6180 per EA (NDC 68382098206), effective Aug 19, 2026.

How has the price of LAMOTRIGINE ER 200 MG TABLET changed over time?

Over the history we have for it, the NADAC for LAMOTRIGINE ER 200 MG TABLET has declined 69.8%. It has been tracked across 305 weekly CMS publications since Oct 21, 2020.

What are the highest and lowest recorded NADAC prices for LAMOTRIGINE ER 200 MG TABLET?

Since Oct 21, 2020, the NADAC for LAMOTRIGINE ER 200 MG TABLET has ranged from a low of $0.4877 (Nov 20, 2024) to a high of $2.3296 (Oct 13, 2021), with a median of $0.9191 per EA.

Are there cheaper alternatives to LAMOTRIGINE ER 200 MG TABLET?

Yes. 16 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LAMOTRIGINE 200 MG TABLET, is $0.0838 per EA — about 86% below LAMOTRIGINE ER 200 MG TABLET.

Who manufactures LAMOTRIGINE ER 200 MG TABLET?

LAMOTRIGINE ER 200 MG TABLET (NDC 68382098206) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.